Back to Journals » Journal of Hepatocellular Carcinoma » Volume 9

Journal of Hepatocellular Carcinoma


Archive: Volume 9, 2022

Hepatocellular Carcinoma Due to Nonalcoholic Fatty Liver Disease: Current Concepts and Future Challenges

Ahmad MI, Khan MU, Kodali S, Shetty A, Bell SM, Victor D

Journal of Hepatocellular Carcinoma 2022, 9:477-496

Published Date: 1 June 2022

CT-Based Radiomics for the Recurrence Prediction of Hepatocellular Carcinoma After Surgical Resection

Wang F, Chen Q, Zhang Y, Chen Y, Zhu Y, Zhou W, Liang X, Yang Y, Hu H

Journal of Hepatocellular Carcinoma 2022, 9:453-465

Published Date: 23 May 2022

Application of the CT/MRI LI-RADS Treatment Response Algorithm to Contrast-Enhanced Ultrasound: A Feasibility Study

Ruan SM, Cheng MQ, Huang H, Hu HT, Li W, Xie XY, Lu MD, Kuang M, Lin MX, Wang W

Journal of Hepatocellular Carcinoma 2022, 9:437-451

Published Date: 20 May 2022

RNA Binding Motif Protein 3 Promotes Cell Metastasis and Epithelial–Mesenchymal Transition Through STAT3 Signaling Pathway in Hepatocellular Carcinoma

Zhang L, Zhang Y, Shen D, Chen Y, Feng J, Wang X, Ma L, Liao Y, Tang L

Journal of Hepatocellular Carcinoma 2022, 9:405-422

Published Date: 9 May 2022

Identification and Validation of Novel Biomarkers for Hepatocellular Carcinoma, Liver Fibrosis/Cirrhosis and Chronic Hepatitis B via Transcriptome Sequencing Technology

Zhao D, Zhang X, Tang Y, Guo P, Ai R, Hou M, Wang Y, Yuan X, Cui L, Zhang Y, Zhao S, Li W, Wang Y, Sun X, Liu L, Dong S, Li L, Zhao W, Nan Y

Journal of Hepatocellular Carcinoma 2022, 9:389-403

Published Date: 9 May 2022

Macrotrabecular-Massive Hepatocellular Carcinoma: What Should We Know?

Li X, Yao Q, Liu C, Wang J, Zhang H, Li S, Cai P

Journal of Hepatocellular Carcinoma 2022, 9:379-387

Published Date: 5 May 2022

An Overview of Hepatocellular Carcinoma After Insufficient Radiofrequency Ablation

Guo Y, Ren Y, Dong X, Kan X, Zheng C

Journal of Hepatocellular Carcinoma 2022, 9:343-355

Published Date: 26 April 2022

Antiviral Treatments Eliminate the Adverse Impacts of High Baseline HBV Loads on the Survival of HBV-Related HCC Patients

Hu Z, Sun X, Mei J, Hu Z, Yang Z, Hou J, Fu Y, Wang X, Chen M

Journal of Hepatocellular Carcinoma 2022, 9:315-325

Published Date: 19 April 2022

Impact of PNPLA3 p.I148M and Hepatic Steatosis on Long-Term Outcomes for Hepatocellular Carcinoma and HBsAg Seroclearance in Chronic Hepatitis B

Hsueh RC, Wu WJ, Lin CL, Liu CJ, Huang YW, Hu JT, Wu CF, Sung FY, Liu WJ, Yu MW

Journal of Hepatocellular Carcinoma 2022, 9:301-313

Published Date: 11 April 2022

MCT4 Promotes Hepatocellular Carcinoma Progression by Upregulating TRAPPC5 Gene

Niu Z, Yang F, Li H, Wang J, Ni Q, Ma C, Zhu H, Chang H, Zhou X, Lu J, Gao H

Journal of Hepatocellular Carcinoma 2022, 9:289-300

Published Date: 8 April 2022

Autoantibody Against Ferritin Light Chain is a Serum Biomarker for the Detection of Liver Cirrhosis but Not Liver Cancer

Ren P, Wang K, Ma J, Cao X, Zhao J, Zhao C, Guo Y, Ye H

Journal of Hepatocellular Carcinoma 2022, 9:221-232

Published Date: 29 March 2022

LRP1B is a Potential Biomarker for Tumor Immunogenicity and Prognosis of HCC Patients Receiving ICI Treatment

Cheng Y, Tang R, Li X, Wang B, Cheng Y, Xiao S, Sun P, Yu W, Li C, Lin X, Zhu Y

Journal of Hepatocellular Carcinoma 2022, 9:203-220

Published Date: 22 March 2022

Preoperative Radiomics Analysis of Contrast-Enhanced CT for Microvascular Invasion and Prognosis Stratification in Hepatocellular Carcinoma

Xu T, Ren L, Liao M, Zhao B, Wei R, Zhou Z, He Y, Zhang H, Chen D, Chen H, Liao W

Journal of Hepatocellular Carcinoma 2022, 9:189-201

Published Date: 20 March 2022

Borealin Promotes Tumor Growth and Metastasis by Activating the Wnt/β-Catenin Signaling Pathway in Hepatocellular Carcinoma

Chen B, Gu Y, Shen H, Liu Q, Wang H, Li Y, Liu X, Liu Y, Du Q, Sun H, Liao X

Journal of Hepatocellular Carcinoma 2022, 9:171-188

Published Date: 11 March 2022

Regorafenib Combined with PD-1 Blockade Immunotherapy versus Regorafenib as Second-Line Treatment for Advanced Hepatocellular Carcinoma: A Multicenter Retrospective Study

Huang J, Guo Y, Huang W, Hong X, Quan Y, Lin L, Zhou J, Liang L, Zhang Y, Zhou J, Cai M, Zhu K

Journal of Hepatocellular Carcinoma 2022, 9:157-170

Published Date: 10 March 2022

The Oncogenic and Diagnostic Potential of Stanniocalcin 2 in Hepatocellular Carcinoma

Wu Z, Cheng H, Liu J, Zhang S, Zhang M, Liu F, Li Y, Huang Q, Jiang Y, Chen S, Lv L, Li D, Zeng JZ

Journal of Hepatocellular Carcinoma 2022, 9:141-155

Published Date: 8 March 2022

Postoperative Adjuvant Transarterial Chemoembolization Plus Tyrosine Kinase Inhibitor for Hepatocellular Carcinoma: a Multicentre Retrospective Study

Lin K, Wei F, Huang Q, Lai Z, Zhang J, Chen Q, Jiang Y, Kong J, Tang S, Lin J, Chen Y, Chen J, Zeng Y

Journal of Hepatocellular Carcinoma 2022, 9:127-140

Published Date: 8 March 2022

MicroRNA-128-3p Mediates Lenvatinib Resistance of Hepatocellular Carcinoma Cells by Downregulating c-Met

Xu X, Jiang W, Han P, Zhang J, Tong L, Sun X

Journal of Hepatocellular Carcinoma 2022, 9:113-126

Published Date: 27 February 2022

Current Perspectives on the Unique Roles of Exosomes in Drug Resistance of Hepatocellular Carcinoma

Xue D, Han J, Liang Z, Jia L, Liu Y, Tuo H, Peng Y

Journal of Hepatocellular Carcinoma 2022, 9:99-112

Published Date: 18 February 2022

SLC39A1 Overexpression is Associated with Immune Infiltration in Hepatocellular Carcinoma and Promotes Its Malignant Progression

Ma X, Zhuang H, Wang Q, Yang L, Xie Z, Zhang Z, Tan W, Tang C, Chen Y, Shang C

Journal of Hepatocellular Carcinoma 2022, 9:83-98

Published Date: 15 February 2022

Hepatocellular Carcinoma Risk Prediction in the NIH-AARP Diet and Health Study Cohort: A Machine Learning Approach

Thomas J, Liao LM, Sinha R, Patel T, Antwi SO

Journal of Hepatocellular Carcinoma 2022, 9:69-81

Published Date: 15 February 2022

CtBP1 Mediates Hypoxia-Induced Sarcomatoid Transformation in Hepatocellular Carcinoma

Zhang X, Wang X, Jia L, Yang Y, Yang F, Xiao S

Journal of Hepatocellular Carcinoma 2022, 9:57-67

Published Date: 11 February 2022

Current Perspective of Traditional Chinese Medicines and Active Ingredients in the Therapy of Hepatocellular Carcinoma

Li Y, Li Y, Zhang J, Ji L, Li M, Sun X, Feng H, Yu Z, Gao Y

Journal of Hepatocellular Carcinoma 2022, 9:41-56

Published Date: 9 February 2022

Dynamic Lymphocyte Changes Following Transarterial Radioembolization: Association with Normal Liver Dose and Effect on Overall Survival

Young S, Ragulojan R, Chen T, Owen J, D'souza D, Sanghvi T, Golzarian J, Flanagan S

Journal of Hepatocellular Carcinoma 2022, 9:29-39

Published Date: 4 February 2022

Factors Associated with Survival of Hepatocellular Carcinoma (HCC) Patients at a Safety Net Hospital in Arizona without On-Site Liver Transplant Program

Turse E, Aboona M, Charley E, Forlemu A, Bowie T, Bhattarai B, Chuang KY, Nadir A

Journal of Hepatocellular Carcinoma 2022, 9:1-11

Published Date: 22 January 2022